ArticleHaematologica2015
Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
Abstract readLetter
In one paragraph
Article in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A genetic variation associated with plasma erythropoietin and a non-coding transcript of PRKAR1A in sickle cell disease.Human molecular genetics · 2016Pooled it
- Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa.British journal of haematology · 2024Trial
- Gene-environmental influence of space and microgravity on red blood cells with sickle cell disease.NPJ genomic medicine · 2024Review
- A preliminary study of phosphodiesterases and adenylyl cyclase signaling pathway on red blood cell deformability of sickle cell patients.Frontiers in physiology · 2023Article
- The impact of Hydroxyurea on the rates of Vaso-occlusive crises in patients with sickle cell disease in Saudi Arabia: a single-center study.BMC emergency medicine · 2022Article
- Drop-of-sample rheometry of biological fluids by noncontact acoustic tweezing spectroscopy.Lab on a chip · 2022Article
- Characterizing bulk rigidity of rigid red blood cell populations in sickle-cell disease patients.Scientific reports · 2021Article
- Article
- A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic.Orphanet journal of rare diseases · 2021Review
- Rheological Impact of GBT1118 Cessation in a Sickle Mouse Model.Frontiers in physiology · 2021Article
- Exercise-induced haemoglobin oxygen desaturation in patients with SCD.American journal of cardiovascular disease · 2021Article
- One-Fifth of Children with Sickle Cell Anemia Show Exercise-Induced Hemoglobin Desaturation: Rate of Perceived Exertion and Role of Blood Rheology.Journal of clinical medicine · 2020Article
- Blood rheology biomarkers in sickle cell disease.Experimental biology and medicine (Maywood, N.J.) · 2020Review
- Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management.Hematology. American Society of Hematology. Education Program · 2019Review
- Impact of A Six Week Training Program on Ventilatory Efficiency, Red Blood Cell Rheological Parameters and Red Blood Cell Nitric Oxide Signaling in Young Sickle Cell Anemia Patients: A Pilot Study.Journal of clinical medicine · 2019Article
- Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise.Frontiers in physiology · 2019Review
- Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia.European journal of haematology · 2018Article
- Shape oscillations of single blood drops: applications to human blood and sickle cell disease.Scientific reports · 2018Article
- Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?Clinical hemorheology and microcirculation · 2018Article
- Identification of therapeutic targets for inflammation in sickle cell disease (SCD) among Indian patients using gene expression data analysis.Bioinformation · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Nathalie LemonneUnité Transversale de la Drépanocytose, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe.
Keyne CharlotInserm UMR 1134, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe Laboratoire d'Excellence GR-Ex « The red cell: from genesis to death », PRES Sorbonne Paris Cité, 75015, Paris, France.
Xavier WaltzInserm UMR 1134, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe Laboratoire d'Excellence GR-Ex « The red cell: from genesis to death », PRES Sorbonne Paris Cité, 75015, Paris, France.
Samir K BallasDepartment of Medicine, Cardeza Foundation for Hematologic Research, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Yann LamarreInserm UMR 1134, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe Laboratoire d'Excellence GR-Ex « The red cell: from genesis to death », PRES Sorbonne Paris Cité, 75015, Paris, France.
Ketty LeeLaboratoire de génétique moléculaire, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe.
Régine HiersoInserm UMR 1134, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe Laboratoire d'Excellence GR-Ex « The red cell: from genesis to death », PRES Sorbonne Paris Cité, 75015, Paris, France.
Catherine ConnesInserm UMR 1134, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe Laboratoire d'Excellence GR-Ex « The red cell: from genesis to death », PRES Sorbonne Paris Cité, 75015, Paris, France.
Maryse Etienne-JulanUnité Transversale de la Drépanocytose, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe.
Marc RomanaInserm UMR 1134, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe Laboratoire d'Excellence GR-Ex « The red cell: from genesis to death », PRES Sorbonne Paris Cité, 75015, Paris, France.
Philippe ConnesInserm UMR 1134, Hôpital Ricou, CHU de Pointe-à-Pitre, Guadeloupe Laboratoire d'Excellence GR-Ex « The red cell: from genesis to death », PRES Sorbonne Paris Cité, 75015, Paris, France Institut Universitaire de France, Paris, France Laboratoire CRIS EA647, Section "Vascular Biology and Red Blood Cell", Université Claude Bernard Lyon 1, France pconnes@yahoo.fr.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAnemia, Sickle CellAntisickling AgentsBlood ViscosityErythrocyte DeformabilityFemaleHematocritHumansHydroxyureaMaleMiddle AgedAntisickling AgentsHydroxyureahaemorheologyhydroxyureasickle cell disease
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.